There were no significant differences detectable for the frequency of HLA-DR+/CD38+ and PD-1+ cells when we compared CD39+ and CD39– T-cell subsets from healthy individuals with those from IBD patients (Supplementary Figure S4A). This evidence concerns the gene ENTPD1 and inflammatory bowel disease.